FR2646605B1 - Activateur de neurones endommages, servant a la prevention et au traitement de maladies - Google Patents

Activateur de neurones endommages, servant a la prevention et au traitement de maladies

Info

Publication number
FR2646605B1
FR2646605B1 FR898915798A FR8915798A FR2646605B1 FR 2646605 B1 FR2646605 B1 FR 2646605B1 FR 898915798 A FR898915798 A FR 898915798A FR 8915798 A FR8915798 A FR 8915798A FR 2646605 B1 FR2646605 B1 FR 2646605B1
Authority
FR
France
Prior art keywords
activator
prevention
treatment
diseases
damaged
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR898915798A
Other languages
English (en)
French (fr)
Other versions
FR2646605A1 (fr
Inventor
Shigemi Fujisaki
Takashi Fujisaki
Junichi Yoshida
Yasuhiro Fujisaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2646605A1 publication Critical patent/FR2646605A1/fr
Application granted granted Critical
Publication of FR2646605B1 publication Critical patent/FR2646605B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
FR898915798A 1989-05-08 1989-11-30 Activateur de neurones endommages, servant a la prevention et au traitement de maladies Expired - Lifetime FR2646605B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1114852A JPH02292226A (ja) 1989-05-08 1989-05-08 障害された神経細胞賦活予防治療剤

Publications (2)

Publication Number Publication Date
FR2646605A1 FR2646605A1 (fr) 1990-11-09
FR2646605B1 true FR2646605B1 (fr) 1992-08-07

Family

ID=14648320

Family Applications (1)

Application Number Title Priority Date Filing Date
FR898915798A Expired - Lifetime FR2646605B1 (fr) 1989-05-08 1989-11-30 Activateur de neurones endommages, servant a la prevention et au traitement de maladies

Country Status (4)

Country Link
JP (1) JPH02292226A (enrdf_load_stackoverflow)
DE (2) DE3943649C2 (enrdf_load_stackoverflow)
FR (1) FR2646605B1 (enrdf_load_stackoverflow)
GB (1) GB2231263A (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1682168B1 (en) 2003-10-29 2013-05-01 Eli Lilly And Co. Non-pancreatic proteases for controlling plasma cholecystokinin (cck) concentration and for treating pain
GB2450747A (en) * 2007-07-06 2009-01-07 Univ Sheffield Treatment of sensorineural hearing loss
CN109295041A (zh) * 2018-10-10 2019-02-01 宁波希诺亚海洋生物科技有限公司 具有舍雷肽酶活性的多肽及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1064581A (en) * 1964-04-06 1967-04-05 Rorer Inc William H Preparations containing an antitussive and an enzyme
FR5218M (enrdf_load_stackoverflow) * 1965-06-18 1967-07-03
DE1955844A1 (de) * 1969-11-06 1971-05-19 Blendax Werke Schneider Co Mittel zur Behandlung von Entzuendungen
US3860702A (en) * 1972-07-11 1975-01-14 Schuyler Dev Corp Anti-inflammatory compositions
JPS57128634A (en) * 1981-02-03 1982-08-10 Eisai Co Ltd Elastase-containing compound increasing absorption
JPS5826822A (ja) * 1981-08-10 1983-02-17 Kaken Pharmaceut Co Ltd 慢性腎炎治療剤
JPS58189122A (ja) * 1982-04-30 1983-11-04 Kaken Pharmaceut Co Ltd 高脂血症予防治療剤
WO1984002846A1 (en) * 1983-01-21 1984-08-02 Advanced Drug Tech Enzyme ointment
JPS59225122A (ja) * 1983-05-23 1984-12-18 Kaken Pharmaceut Co Ltd 悪液質治療改善剤
JPS608227A (ja) * 1983-06-28 1985-01-17 Kaken Pharmaceut Co Ltd 抗アレルギ−増強剤
US4844897A (en) * 1985-09-13 1989-07-04 Hiroshi Maeda Anti-tumor protease preparations
JPS62215533A (ja) * 1986-03-17 1987-09-22 Shigemi Fujisaki 膠原病又は関節リウマチの予防治療剤
EP0252004A1 (de) * 1986-06-26 1988-01-07 Ciba-Geigy Ag Pharmazeutische Zusammensetzungen für die parenterale Applikation
JPS63295515A (ja) * 1987-05-26 1988-12-01 Kao Corp 腸溶性抗血液凝固・血栓溶解製剤
CH680285A5 (enrdf_load_stackoverflow) * 1987-10-02 1992-07-31 Ferag Ag

Also Published As

Publication number Publication date
GB8928811D0 (en) 1990-02-28
JPH02292226A (ja) 1990-12-03
GB2231263A (en) 1990-11-14
FR2646605A1 (fr) 1990-11-09
DE3941324A1 (de) 1990-11-15
JPH0577655B2 (enrdf_load_stackoverflow) 1993-10-27
DE3941324C2 (enrdf_load_stackoverflow) 1992-06-25
DE3943649C2 (enrdf_load_stackoverflow) 1992-10-29

Similar Documents

Publication Publication Date Title
ES2164842T3 (es) Procedimiento para la preparacion de composiciones de microcapsulas.
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
HUP9801240A2 (en) Oral compositions
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
BR9814743A (pt) Tablete de detergente
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ATE210988T1 (de) Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen
DE69124371D1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
NO990405L (no) Substituerte N-(indol-2-karbonyl)-glycinamider og derivater som antidiabetiske midler
FI924553A0 (fi) Tiofensulfonamider anvaendbara som kolanhydrasinhibitorer
BG102616A (en) Substituted aza- and diazacycloheptane and cyclooctane derivatives and their application
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
ES2119185T3 (es) Tratamiento de enfermedades micobacterianas por administracion de productos de la proteina bactericida/que aumenta la permeabilidad.
IL94278A0 (en) 2-saccharine derivatives,their preparation and pharmaceutical compositions containing them
DE69636285D1 (de) ISOLIERTES FrpB NUKLEINSÄUREMOLEKÜL UND ENTSPRECHENDE IMPFSTOFF
BR9812222A (pt) Preparação farmacêutica separada de complexo de protrombina, preparação diagnóstica, e, utilização de uma preparação
NO980296D0 (no) Forbedrede terapeutiske midler
WO2003031585A3 (en) Transmembrane serine protease 25
FR2646605B1 (fr) Activateur de neurones endommages, servant a la prevention et au traitement de maladies
NO974561D0 (no) Chlamydia-vaksine
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
PT1150703E (pt) Terapia de esclerose multipla com chaperonina 10 e beta-interferao
NO180642C (no) Alkalipullulanase og renisolert kultur av Bacillus sp. mikroorganisme som produserer denne
EA199700243A1 (ru) Производное аминотетралина для лечения сердечно-сосудистых заболеваний
ES2034678T3 (es) Procedimiento para aumentar la productividad de los cerdos.

Legal Events

Date Code Title Description
ST Notification of lapse